HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hemoglobin Knossos: a clinical, laboratory, and epidemiological study.

Abstract
Hb Knossos is a beta-chain variant (beta 27 Ser----Ala) that is unrecognizable by conventional separation methods but detectable by globin electrophoresis on urea-Triton X-acrylamide gels or by IEF. Hb Knossos is characterized by reduced synthesis and by interaction with beta-thalassemia, in which the double heterozygotes display typical features of thalassemia intermedia. The present paper summarizes the salient genetic, clinical, and biochemical characteristics of five such cases hitherto identified in three families along with the same features on 12 heterozygous Hb Knossos carriers. Hb Knossos displays a slightly decreased oxygen affinity; this factor may compensate in part for the severe anemia of the double heterozygotes. Hb Knossos is relatively rare in our population, since a prospective survey on 610 individuals has failed to disclose any heterozygotes. However, the mutation appears to have spread over the Mediterranean countries and may be more common elsewhere.
AuthorsP Fessas, D Loukopoulos, S Kokkinou, Y Papasotiriou, A Karaklis
JournalAmerican journal of hematology (Am J Hematol) Vol. 21 Issue 2 Pg. 119-33 (Feb 1986) ISSN: 0361-8609 [Print] United States
PMID3942130 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Diphosphoglyceric Acids
  • Hemoglobins, Abnormal
  • hemoglobin Knossos
  • Oxygen
Topics
  • Adolescent
  • Adult
  • Diphosphoglyceric Acids (blood)
  • Erythrocyte Aging
  • Erythrocytes, Abnormal (pathology)
  • Female
  • Hemoglobins, Abnormal (genetics)
  • Heterozygote
  • Humans
  • Hydrogen-Ion Concentration
  • Isoelectric Point
  • Male
  • Middle Aged
  • Oxygen (blood)
  • Pedigree
  • Thalassemia (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: